Search results
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 7 days ago...biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that Benjamin Bakall, MD, PhD, Director of Clinical Research at Associated Retina Consultants and Clinical Assistant Professor at the University of Arizona,...
Nearsightedness is at epidemic levels – and the problem begins in childhood | Expert Opinion
Philly.com· 14 hours agoMyopia, or the need for corrected vision to focus or see objects at a distance, has become a lot...
Einstein Probe X-ray telescope releases 1st images taken with 'lobster vision'
Space via Yahoo News· 5 days agoOne the right is a diagram of the size of these square pores. (Image credit: ESA/J. ...purpose. The...
Is Algae Oil the New Fish Oil?
Men's Health via Yahoo News· 5 days agoAlgae oil is all the rage right now as a vegetarian replace to fish oil. Dietitians explain its health benefits, uses, and risks associated with using...
Light Exposure Linked to Sharper Cognitive Skills, Study Finds
SciTechDaily· 3 days agoResearch indicates that increased light exposure can enhance activity in a part of the brain known...
3D printed surgical implants may support cures for blindness, chronic pain and neurological diseases
Medical Xpress· 6 days agoThink blindness, deafness, chronic pain, epilepsy, motor neuron disease, and Parkinson's disease....
Atsena Therapeutics Announces Positive Clinical Data from the First Cohort of Phase I/II Trial...
Benzinga· 4 days agoATSN-201 utilizes AAV.SPR, the company's novel spreading capsid, to achieve therapeutic levels of gene expression in photoreceptors of the central retina while avoiding the ...
A Revolution In Gene Therapy Is Unfolding, Bringing Hope for Vision Loss
Newswise· 3 days agoTwo treatments for retinal diseases, invented by Neena Haider, PhD, that currently are in clinical trials run by Ocugen, represent a conceptually broad, new approach that ...
Earnings call: Astellas Pharma exceeds revenue forecast, faces profit dip
Investing.com· 7 days agoAstellas Pharma Inc. (ALPMY) reported a surpassing of its full-year revenue forecast for FY 2023,...
Johnson & Johnson Highlights Commitment to Transform Treatment of Retinal Diseases at ARVO 2024
The Grass Valley Union· 2 days agoCompany to present, across eight data presentations, new real-world research on the economic value of genetic testing for retinal diseases and the role of automatic deep-learning based algorithms for geographic